Physician profile
Joshua Silverstein
NPI 1952587743
$556,937.61
in general payments reported to CMS, 2019-2025
17 companies · $133K in 2025
The $133K reported for 2025 was more than what 99% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $48K · 2020: $61K · 2021: $56K · 2022: $55K · 2023: $88K · 2024: $115K · 2025: $133K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $244K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $39K · Travel and Lodging: $33K · Food and Beverage: $15K · Honoraria: $4,100.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $244,429.20 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $39,399.00 |
| Travel and Lodging | $32,985.35 |
| Food and Beverage | $14,717.46 |
| Honoraria | $4,100.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $233,692.13 | 2019-2025 | Carto 3 |
| Biosense Webster, INC. | $198,908.28 | 2019-2025 | Carto 3, Thermocool Smarttouch, Qdot Micro Catheter |
| Medtronic, INC. | $95,173.74 | 2021-2025 | Affera Mapping System, Micra, Evera Mri Xt Dr Surescan |
| Medtronic Vascular, INC. | $13,215.10 | 2019-2020 | |
| Impulse Dynamics (USA) INC. | $6,437.46 | 2022-2025 | Optimizer, Optimizer |
| Abbott Laboratories | $4,097.99 | 2021-2025 | Aveir, Tendril, Ensite Precision |
| Atricure, INC. | $2,350.97 | 2022 | |
| Volta Medical INC | $1,964.22 | 2022-2023 | Vx1 |
| Boston Scientific Corporation | $644.28 | 2019-2025 | Watchman, Farapulse, Watchman Flx |
| Philips North America LLC | $121.34 | 2019-2024 | (Am5) Lead Management |
| Novartis Pharmaceuticals Corporation | $113.13 | 2023-2025 | |
| Ethicon US, LLC | $54.57 | 2024-2025 | Stratafix, Surgicel Nu-Knit, Evarrest |
| E.R. Squibb & Sons, L.L.C. | $51.51 | 2021-2023 | Eliquis |
| Pfizer INC. | $50.05 | 2022 | |
| Angiodynamics, INC. | $36.30 | 2023 | Alphavac |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Altathera Pharmaceuticals LLC | $15.07 | 2024-2025 | Sotalol Hydrochloride |
| Abiomed | $11.47 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshua Silverstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.